2024
The early COVID-19 pandemic period and associated gestational weight gain
Madein A, Lundsberg L, Culhane J, Partridge C, Son M, Merriam A. The early COVID-19 pandemic period and associated gestational weight gain. Journal Of Perinatal Medicine 2024, 0 PMID: 39485230, DOI: 10.1515/jpm-2024-0088.Peer-Reviewed Original ResearchGestational weight gainGestational ageWeight gainAssociated with weight gainInstitute of MedicineMaternal weight gainWeight gain riskRetrospective cohort studyInstitute of Medicine recommendationsTertiary care hospitalNo significant differenceEarly pandemic periodCohort studyPrimary outcomeMedical record dataCare hospitalPandemic groupPandemic epochSignificant differenceLogistic regressionElectronic medical record dataExposure groupMultinominal logistic regressionPandemic periodAgeLate-Onset Postpartum Hypertension After Normotensive Pregnancy.
Sinnott C, Lundsberg L, Culhane J, Partridge C, Denoble A. Late-Onset Postpartum Hypertension After Normotensive Pregnancy. Obstetrics And Gynecology 2024 PMID: 39361961, DOI: 10.1097/aog.0000000000005751.Peer-Reviewed Original ResearchMonths postpartumAcademic health care systemHealth care systemElectronic medical recordsPostpartum carePrimary careRetrospective cohort studyBlood pressureCare systemEvidence of hypertensionWeeks postpartumPostpartum periodCohort studyPostpartum hypertensionPostpartumAmerican CollegeImmediately postpartumMedical recordsAssociation criteriaCareNormotensive pregnanciesBP abnormalitiesNormotensive cohortLate-onsetPregnancySevere Maternal Morbidity in Polycystic Ovary Syndrome
McKenney K, Culhane J, Son M, Burris H, Handley S, Greenspan J, Dysart K. Severe Maternal Morbidity in Polycystic Ovary Syndrome. American Journal Of Obstetrics & Gynecology MFM 2024, 6: 101448. PMID: 39095022, DOI: 10.1016/j.ajogmf.2024.101448.Peer-Reviewed Original ResearchFor Patients Undergoing an Induction of Labor, Does Increased Body Mass Index Necessitate Higher Doses of Misoprostol? [ID 2683640]
Mason-Otey A, Lundsberg L, Culhane J, Merriam A. For Patients Undergoing an Induction of Labor, Does Increased Body Mass Index Necessitate Higher Doses of Misoprostol? [ID 2683640]. Obstetrics And Gynecology 2024, 143: 46s-46s. DOI: 10.1097/01.aog.0001013576.14925.24.Peer-Reviewed Original ResearchInduction of laborBody mass indexBody mass index categoriesDose of misoprostolMisoprostol doseClass IIIMass indexProlonged induction of laborClass IIAssociated with increased BMIClass IIncreased BMIPre-gestational diabetesClass II obesityClass I obesityRetrospective cohort analysisMisoprostol administrationObese patientsII obesityMisoprostolInvestigate safetyHigh dosesPrimary outcomeCohort analysisPatientsAssociation Between Intrapartum Nitrous Oxide for Labor Analgesia and Short-Term Neonatal Outcomes
Starosta A, Lundsberg L, Culhane J, Partridge C, Grechukhina O, Son M. Association Between Intrapartum Nitrous Oxide for Labor Analgesia and Short-Term Neonatal Outcomes. Obstetrics And Gynecology 2024, 143: 677-682. PMID: 38484306, DOI: 10.1097/aog.0000000000005554.Peer-Reviewed Original ResearchShort-term neonatal outcomesNeonatal intensive care unitNo analgesiaNeonatal outcomesApgar scoreLabor analgesiaComposite outcomeAdverse short-term neonatal outcomesNeonatal intensive care unit admissionSecondary outcomesSingle-center retrospective cohortRetrospective cohort study of individualsCohort study of individualsLow-risk patientsRetrospective cohort studyIntensive care unitElectronic medical recordsNitrous oxide useAnalgesia typeIntrapartum cesareanSingleton gestationsNICU admissionNitrous oxide exposureIntrapartum analgesiaNeonatal hyperbilirubinemiaAbsence of Adverse Maternal and Neonatal Outcomes in Patients with 1 or 2 Abnormal Values During Early Glucose Tolerance Testing
Geng B, Lundsberg L, Culhane J, Merriam A. Absence of Adverse Maternal and Neonatal Outcomes in Patients with 1 or 2 Abnormal Values During Early Glucose Tolerance Testing. American Journal Of Obstetrics And Gynecology 2024, 230: e103-e107. PMID: 38242338, DOI: 10.1016/j.ajog.2024.01.007.Peer-Reviewed Original ResearchCo-existing chronic hypertension and hypertensive disorders of pregnancy and associated adverse pregnancy outcomes
Sweeney L, Lundsberg L, Culhane J, Partridge C, Son M. Co-existing chronic hypertension and hypertensive disorders of pregnancy and associated adverse pregnancy outcomes. The Journal Of Maternal-Fetal & Neonatal Medicine 2024, 37: 2305675. PMID: 38290827, DOI: 10.1080/14767058.2024.2305675.Peer-Reviewed Original ResearchConceptsHypertensive disorders of pregnancyDisorders of pregnancyNeonatal outcomesChronic hypertensionHypertensive disordersIntensive care unitCesarean deliveryOdds of cesarean deliveryPregnant personsBlood pressureBivariate tests of associationHypertensive conditionsMaternal ICU admissionPreterm birth <Intensive care unit admissionAntihypertensive medication useBaseline clinical dataElectronic medical recordsTests of associationRetrospective cohort studySGA birthweightEligible peopleGestational ageMaternal comorbiditiesSingleton deliveriesRate of clinically significant red blood cell antibody seroconversion in pregnancy
Ding J, Abels E, Jacobs J, Culhane J, Lundsberg L, Partridge C, Denoble A, Kohari K. Rate of clinically significant red blood cell antibody seroconversion in pregnancy. The Journal Of Maternal-Fetal & Neonatal Medicine 2024, 37: 2419370. PMID: 39462637, DOI: 10.1080/14767058.2024.2419370.Peer-Reviewed Original ResearchConceptsNeonatal intensive care unitAdvanced maternal ageAssociated with seroconversionClinically significant antibodiesAntibody screeningNeonatal outcomesIncreasing gravidityAntibody seroconversionInitial hemoglobinMaternal ageSignificant antibodiesAntibody statusNeonatal intensive care unit admissionCohort studyClinically significant RBC antibodiesAnti-CUnexplained fetal lossPositive antibody screenNegative antibody screenCases of stillbirthRetrospective cohort studyIntensive care unitWilcoxon rank-sumMaternal antibody statusPostnatal transfusion284 Postpartum diabetes screening rates and 1-year outcomes for individuals with early onset gestational diabetes
Pifer B, Geng B, Lundsberg L, Culhane J, Partridge C, Merriam A. 284 Postpartum diabetes screening rates and 1-year outcomes for individuals with early onset gestational diabetes. American Journal Of Obstetrics And Gynecology 2024, 230: s163-s164. DOI: 10.1016/j.ajog.2023.11.306.Peer-Reviewed Original Research1083 Risk of Severe Maternal Morbidity in Polycystic Ovary Syndrome
McKenney K, Culhane J, Son M, Dysart K. 1083 Risk of Severe Maternal Morbidity in Polycystic Ovary Syndrome. American Journal Of Obstetrics And Gynecology 2024, 230: s568-s569. DOI: 10.1016/j.ajog.2023.11.1110.Peer-Reviewed Original Research599 Differing clinical management for postpartum hemorrhage and associated risk for intensive care unit admission
Son M, Lundsberg L, Dysart K, Partridge C, Burris H, Handley S, Ledyard R, Baisden K, Berhane L, Doamekpor L, Bersoff-Matcha S, Culhane J. 599 Differing clinical management for postpartum hemorrhage and associated risk for intensive care unit admission. American Journal Of Obstetrics And Gynecology 2024, 230: s324-s325. DOI: 10.1016/j.ajog.2023.11.624.Peer-Reviewed Original Research715 Trends in Tdap and Flu Vaccination in Pregnant People in Relation to the COVID-19 Pandemic
Dave E, Culhane J, Lundsberg L, Partridge C, Kohari K, Denoble A. 715 Trends in Tdap and Flu Vaccination in Pregnant People in Relation to the COVID-19 Pandemic. American Journal Of Obstetrics And Gynecology 2024, 230: s382. DOI: 10.1016/j.ajog.2023.11.741.Peer-Reviewed Original Research597 De novo hypertension in the late postpartum period: a case for extending postpartum care
Sinnott C, Stammler S, Lundsberg L, Partridge C, Culhane J, Denoble A. 597 De novo hypertension in the late postpartum period: a case for extending postpartum care. American Journal Of Obstetrics And Gynecology 2024, 230: s323-s324. DOI: 10.1016/j.ajog.2023.11.622.Peer-Reviewed Original Research983 Maternal characteristics associated with delivery versus expectant management when presenting with term decreased fetal movement
Ding J, Lundsberg L, Culhane J, Partridge C, Cross S. 983 Maternal characteristics associated with delivery versus expectant management when presenting with term decreased fetal movement. American Journal Of Obstetrics And Gynecology 2024, 230: s518-s519. DOI: 10.1016/j.ajog.2023.11.1010.Peer-Reviewed Original Research601 Evolution of hypertension stages in pregnancy and postpartum from 2013-2022
Stammler S, Denoble A, Culhane J, Lundsberg L, Partridge C. 601 Evolution of hypertension stages in pregnancy and postpartum from 2013-2022. American Journal Of Obstetrics And Gynecology 2024, 230: s325-s326. DOI: 10.1016/j.ajog.2023.11.626.Peer-Reviewed Original Research427 Delivery and neonatal outcomes associated with delivery versus expectant management following term decreased fetal movement
Ding J, Lundsberg L, Culhane J, Partridge C, Cross S. 427 Delivery and neonatal outcomes associated with delivery versus expectant management following term decreased fetal movement. American Journal Of Obstetrics And Gynecology 2024, 230: s236. DOI: 10.1016/j.ajog.2023.11.453.Peer-Reviewed Original Research425 Effect of the COVID-19 pandemic on population-level mean arterial pressure during pregnancy and postpartum
Denoble A, Stammler S, Partridge C, Lundsberg L, Culhane J. 425 Effect of the COVID-19 pandemic on population-level mean arterial pressure during pregnancy and postpartum. American Journal Of Obstetrics And Gynecology 2024, 230: s235. DOI: 10.1016/j.ajog.2023.11.451.Peer-Reviewed Original Research426 Brain natriuretic peptide testing and severe maternal morbidity in pregnancies affected by heart disease
Denoble A, Federspiel J, Goldstein S, Culhane J, Dysart K. 426 Brain natriuretic peptide testing and severe maternal morbidity in pregnancies affected by heart disease. American Journal Of Obstetrics And Gynecology 2024, 230: s235-s236. DOI: 10.1016/j.ajog.2023.11.452.Peer-Reviewed Original Research
2023
Severe maternal morbidity rates in a US-based electronic health record database, 2018–2022
Son M, Culhane J, Louis J, Handley S, Burris H, Greenspan J, McKenney K, Dysart K. Severe maternal morbidity rates in a US-based electronic health record database, 2018–2022. Journal Of Perinatology 2023, 43: 1316-1318. PMID: 37640810, DOI: 10.1038/s41372-023-01765-7.Peer-Reviewed Original ResearchThe association between a low 50-gram, 1-hour glucose challenge test value and neonatal morbidity
Ding J, Lundsberg L, Culhane J, Patridge C, Milley L, Son M. The association between a low 50-gram, 1-hour glucose challenge test value and neonatal morbidity. The Journal Of Maternal-Fetal & Neonatal Medicine 2023, 36: 2245527. PMID: 37558273, DOI: 10.1080/14767058.2023.2245527.Peer-Reviewed Original ResearchConceptsGlucose challenge test valuesTertiary care academic hospitalDiagnosis of GDMGlycemic screeningGCT valuesNICU admissionNeonatal outcomesMorbidity outcomesAcademic hospitalNeonatal intensive care unit admissionSingle tertiary care academic hospitalIntensive care unit admissionMultivariable logistic regression modelingComposite morbidity outcomeNeonatal morbidity outcomesCare unit admissionRetrospective cohort studyNewborns of mothersRisk of morbidityLogistic regression modelingEligible patientsUnit admissionAntenatal surveillanceGestational diabetesHypertensive disorders